Systems biology: an evolving approach in drug discovery and development

Area of Science:

• Pharmacology and Drug Discovery
• Systems Biology
• Computational Biology

Background:

• Pharmaceutical industry investments in systems biology have not met expectations.
• Genomics-driven drug target identification has led to numerous pipeline failures.
• Traditional drug screening in animal models identified effective compounds with unknown targets.

Purpose of the Study:

• To re-evaluate the efficacy of target-based drug discovery.
• To explore the necessity of multiscale systems modeling for drug development.
• To highlight critical concepts and technologies for future pharmaceutical research.

Main Methods:

• Review of current systems biology approaches in pharmaceutical research.
• Analysis of historical drug discovery paradigms.
• Discussion of emerging technologies for multiscale systems modeling.

Main Results:

• Target-based drug discovery may be suboptimal due to pipeline failures.
• Drugs likely act on multiple targets over time, requiring advanced modeling.
• The concept of 'differentiated drug response' is proposed as a future paradigm.

Conclusions:

• Next-generation multiscale systems modeling is crucial for identifying complex drug actions.
• Understanding differentiated drug responses across tissues and time scales is key.
• Adoption of advanced systems biology approaches is vital for future pharmaceutical innovation.